Toll-like receptors: paving the path to T cell-driven autoimmunity?

Current Opinion in Immunology

Volumn 19, Issue 6, 2007, Pages 611-614

  Marsland, Benjamin J ^a   Kopf, Manfred ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; TOLL LIKE RECEPTOR;

AUTOIMMUNITY; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINE PRODUCTION; EFFECTOR CELL; HOMEOSTASIS; IMMUNE RESPONSE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE;

AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTORS;

EID: 36849048443     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2007.07.022     Document Type: Review

References (32)

1. Lang K.S., Georgiev P., Recher M., Navarini A.A., Bergthaler A., Heikenwalder M., Harris N.L., Junt T., Odermatt B., Clavien P.A., et al. Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling. J Clin Invest 116 (2006) 2456-2463
2. Eriksson U., Ricci R., Hunziker L., Kurrer M.O., Oudit G.Y., Watts T.H., Sonderegger I., Bachmaier K., Kopf M., and Penninger J.M. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med 9 (2003) 1484-1490
3. Lang K.S., Recher M., Junt T., Navarini A.A., Harris N.L., Freigang S., Odermatt B., Conrad C., Ittner L.M., Bauer S., et al. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat Med 11 (2005) 138-145
4. Marsland B.J., Nembrini C., Grun K., Reissmann R., Kurrer M., Leipner C., and Kopf M. TLR ligands act directly upon T cells to restore proliferation in the absence of protein kinase C-theta signaling and promote autoimmune myocarditis. J Immunol 178 (2007) 3466-3473. This study shows that CpG can act directly upon T cells to support survival and proliferation in the absence of Protein Kinase C-theta.
5. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 6 (2006) 823-835
6. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 1 (2001) 135-145
7. Viglianti G.A., Lau C.M., Hanley T.M., Miko B.A., Shlomchik M.J., and Marshak-Rothstein A. Activation of autoreactive B cells by CpG dsDNA. Immunity 19 (2003) 837-847
8. Caramalho I., Lopes-Carvalho T., Ostler D., Zelenay S., Haury M., and Demengeot J. Regulatory T cells selectively express Toll-like receptors and are activated by lipopolysaccharide. J Exp Med 197 (2003) 403-411
9. Hornung V., Rothenfusser S., Britsch S., Krug A., Jahrsdorfer B., Giese T., Endres S., and Hartmann G. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168 (2002) 4531-4537
10. Zarember K.A., and Godowski P.J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 168 (2002) 554-561
11. Sutmuller R.P., den Brok M.H., Kramer M., Bennink E.J., Toonen L.W., Kullberg B.J., Joosten L.A., Akira S., Netea M.G., and Adema G.J. Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 116 (2006) 485-494. This study together with reference 12 shows convincing data that TLR2 signaling directly influences regulatory T cell expansion but question whether LPS can influence T cell function directly.
12. Liu H., Komai-Koma M., Xu D., and Liew F.Y. Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. Proc Natl Acad Sci USA 103 (2006) 7048-7053. See comments for reference [11].
13. Peng G., Guo Z., Kiniwa Y., Voo K.S., Peng W., Fu T., Wang D.Y., Li Y., Wang H.Y., and Wang R.F. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science 309 (2005) 1380-1384
14. Sawaki J., Tsutsui H., Hayashi N., Yasuda K., Akira S., Tanizawa T., and Nakanishi K. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways. Int Immunol 19 (2007) 311-320
15. Lauzon N.M., Mian F., MacKenzie R., and Ashkar A.A. The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity. Cell Immunol 241 (2006) 102-112
16. Wesch D., Beetz S., Oberg H.H., Marget M., Krengel K., and Kabelitz D. Direct costimulatory effect of TLR3 ligand poly(I:C) on human gamma delta T lymphocytes. J Immunol 176 (2006) 1348-1354
17. Marsland B.J., Harris N.L., Camberis M., Kopf M., Hook S.M., and Le Gros G. Bystander suppression of allergic airway inflammation by lung resident memory CD8+ T cells. Proc Natl Acad Sci USA 101 (2004) 6116-6121
18. Chen H.D., Fraire A.E., Joris I., Brehm M.A., Welsh R.M., and Selin L.K. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Nat Immunol 2 (2001) 1067-1076
19. Walzl G., Tafuro S., Moss P., Openshaw P.J., and Hussell T. Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology. J Exp Med 192 (2000) 1317-1326
20. Caron G., Duluc D., Fremaux I., Jeannin P., David C., Gascan H., and Delneste Y. Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells. J Immunol 175 (2005) 1551-1557
21. Komai-Koma M., Jones L., Ogg G.S., Xu D., and Liew F.Y. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc Natl Acad Sci USA 101 (2004) 3029-3034
22. Gelman A.E., Zhang J., Choi Y., and Turka L.A. Toll-like receptor ligands directly promote activated CD4+ T cell survival. J Immunol 172 (2004) 6065-6073
23. Cottalorda A., Verschelde C., Marcais A., Tomkowiak M., Musette P., Uematsu S., Akira S., Marvel J., and Bonnefoy-Berard N. TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation. Eur J Immunol 36 (2006) 1684-1693
24. Gelman A.E., LaRosa D.F., Zhang J., Walsh P.T., Choi Y., Sunyer J.O., and Turka L.A. The adaptor molecule MyD88 activates PI-3 kinase signaling in CD4+ T cells and enables CpG oligodeoxynucleotide-mediated costimulation. Immunity 25 (2006) 783-793. This study shows that CpG mediates T cell survival and proliferation through distinct MyD88 motifs.
25. Bachmann M.F., McKall-Faienza K., Schmits R., Bouchard D., Beach J., Speiser D.E., Mak T.W., and Ohashi P.S. Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. Immunity 7 (1997) 549-557
26. Berg-Brown N.N., Gronski M.A., Jones R.G., Elford A.R., Deenick E.K., Odermatt B., Littman D.R., and Ohashi P.S. PKCtheta signals activation versus tolerance in vivo. J Exp Med 199 (2004) 743-752
27. Sonderegger I., Rohn T.A., Kurrer M.O., Iezzi G., Zou Y., Kastelein R.A., Bachmann M.F., and Kopf M. Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis. Eur J Immunol 36 (2006) 2849-2856
28. Crellin N.K., Garcia R.V., Hadisfar O., Allan S.E., Steiner T.S., and Levings M.K. Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J Immunol 175 (2005) 8051-8059
29. Wan Y.Y., and Flavell R.A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445 (2007) 766-770
30. Yang Y., Huang C.T., Huang X., and Pardoll D.M. Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. Nat Immunol 5 (2004) 508-515
31. Imanishi T., Hara H., Suzuki S., Suzuki N., Akira A., and Saito T. Cutting edge: TLR2 directly triggers Th1 effector functions. J Immunol 178 (2007) 6715-6719
32. Zanin-Zhorov A., Tal-Lapidot G., Cahalon L., Cohen-Sfady M., Pevsner-Fischer M., Lider O., and Cohen I.R. Cutting edge: T cells respond to lipopolysaccharide innately via TLR4 signaling. J Immunol 179 (2007) 41-44